Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: March 24, 2010

Drug Name	Review Type	Class	Manufacturer
Bepreve	New Drug Initial Review	Ophthalmic - Allergic Conjunctivitis	Ista
Vivitrol	New Drug Initial Review	Opioid Antagonist	Alkermes
Colcrys	New Drug Initial Review	Anti-Gout	URL
Sabril	New Drug Initial Review	Anticonvulsant	Lundbeck
Twynsta	New Drug Initial Review	Antihypertensive Combination	Boehringer Ingelheim
Apriso	New Drug Initial Review	Ulcerative Colitis	Salix
Besivance	New Drug Appeal	Ophthalmic Fluoroquinolone	Bausch & Lomb
Ranexa	New Drug Appeal	Anti-Anginal	Giliead
Vimpat	New Drug Appeal	Anticonvulsant	UCB
Lamictal XR	New Drug Appeal	Anticonvulsant	GlaxoSmithKline
Ulesfia	New Drug Appeal	Pediculocide	Shionogi
Zenpep	New Drug Appeal	Pancreatic Enzyme	Eurand
Xibrom	PDL Appeal	Ophthalmic � Anti-Inflammatory	Ista
Istalol	PDL Appeal	Ophthalmic � Glaucoma Agent	Ista

Footer